Brief: Adicet Bio Presents Positive Preclinical Data On Adi-270 At ASGCT 26Th Annual Meeting
18/05/2023 11:06
May 18 (Reuters) - Adicet Bio Inc ACET.O :
* ADICET BIO PRESENTS POSITIVE PRECLINICAL DATA ON ADI-270
AT THE
AMERICAN SOCIETY OF GENE AND CELL THERAPY (ASGCT) 26TH ANNUAL
MEETING
Source text for Eikon: ID:nBw5Cdf9pa
Further company coverage: ACET.O
Recent news on ADICET Bio
See all newsNASDAQ RESUMED AT 09:35 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:30 AM
Brief: Adicet Bio Announces Positive Safety And Efficacy Data From Prula-Cel (Formerly Adi-001) Study In Patients With Systemic Lupus Erythematosus With Or Without Lupus Nephritis
Brief: Adicet Bio Announces FDA Clearance Of Ind Application For Adi-212
Adicet Bio, Inc. Reports Results For The Quarter Ended June 30: Earnings Summary